HopeStage
Back to all studies
CompletedNCT06772987

Three daily brain-stimulation sessions for depression

About this titleRead the official source — NCT06772987
Device studyAges 22–85United States
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 22 years to 85 years. Other eligibility criteria applied.

Listed locations
San JoseSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 16, 2025
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
NeuroQore Inc.
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 85 Years
Official registry ID
NCT06772987
Official title
Show the full official title

Safety and Efficacy of an Accelerated, Rectangular Waveform rTMS Protocol in Treatment of Adults With Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

San Jose

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NeuroQore Inc.

Who was this study for?

This study was for people with depression. Listed age limits: 22 years to 85 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies